Key result
Absolute metrics are essential for plasma monitoring of anti-TFPI therapies to account for pharmacokinetic variability.
Design
Correspondence
Answers are grounded in this paper and cite their sources.
Clinicians must use absolute metrics for anti-TFPI plasma monitoring; extends evidence on pharmacokinetic variability.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lopez et al. (2026) studied this question. Absolute metrics are essential for plasma monitoring of anti-TFPI therapies to accurately account for pharmacokinetic variability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: